The effect of Senitaison vaginal douche in improving vaginal infections of women

Studying the effect of sanitizon vaginal douche compared to Septi body vaginal douche in improving infection in women with vaginal infections

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250701066320N1

Enrollment

Registered

2025-08-03

Start date

2025-08-22

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginitis. Acute vaginitis

Interventions

Intervention 1: Intervention group: The group receiving the vaginal douche Sanitazon produced by the medical equipment and pharmaceutical supplies manufacturer Gohar Shafa with a concentration of 150

Eligibility

Sex/Gender

Female

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Vaginal infections, whether fungal or bacterial Being married

Exclusion criteria

Exclusion criteria: Being infected with HIV Being infected with HCV

Design outcomes

Primary

Measure	Time frame
Improve vaginitis infection. Timepoint: The duration of drug use is 5 days and the improvement is monitored for 5 days after stopping the drug. Method of measurement: Observation by a doctor as well as preparation of a Vetmond slide to check for the presence of disease and Gram staining.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKiana Shahzamani

Khoram-Abad University of Medical Sciences

shahzamani.k@lums.ac.ir+98 66 3330 0661

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026